Independent validation and assay standardization of improved metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.

التفاصيل البيبلوغرافية
العنوان:	Independent validation and assay standardization of improved metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
المؤلفون:	Mahajan, Ujjwal M., Oehrle, B., Sirtl, S., Alnatsha, A., Goni, E., Regel, I., Beyer, G., Vornhülz, M., Chromik, A., Bahra, M., Klein, F., Uhl, W., Fahlbusch, T., Distler, M., Weitz, J., Grützmann, R., Pilarsky, C., Weiss, F. Ulrich, Adam, G., Kalthoff, H.
المصدر:	Pancreatology (Elsevier Science); 2022 Supplement 1, Vol. 22, pe65-e66, 2p
قاعدة البيانات:	Complementary Index

الوصف
تدمد:	14243903
DOI:	10.1016/j.pan.2022.06.170